Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRedcentric Regulatory News (RCN)

Share Price Information for Redcentric (RCN)

Share Price is delayed by 15 minutes
Get Live Data
123.50    1.50 (1.24%)
Bid:
121.00
Ask:
123.50
Spread: 2.50 (2.066%)
Market Cap: £196.76m
RCN Live PriceLast checked at - London Stock Exchange

Intraday Redcentric Share Chart

Director/PDMR Shareholdings

8 Apr 2026 12:55

RNS Number : 6814Z
Redcentric PLC
08 April 2026
 

8 April 2026

 

Redcentric plc

('Redcentric' or the 'Company')

 

Director/PDMR Shareholdings

 

Redcentric plc (AIM:RCN), a leading UK IT managed services provider, announces that it received notification from Mr. Oliver Scott, Non-Executive Director, that an aggregate of 19,500 ordinary shares of 0.1 pence each (all ordinary shares in the company referred to as 'Shares') have been transferred out of Kestrel Partners LLP's ('Kestrel') discretionary management and control due to rearrangement of a client portfolio. These shares continue to be held by the same beneficial owner.

 

Mr. Scott is a partner of, and holds a beneficial interest in, Kestrel. Mr. Scott is also a shareholder in one of Kestrel's clients ('Kestrel Opportunities') and is therefore deemed to have a beneficial interest in Kestrel Opportunities' entire legal holding in Redcentric.

 

Following this notification, Kestrel Opportunities continues to hold (and consequently Mr. Scott is deemed to have a beneficial interest in) 16,715,306 Ordinary Shares in the Company. Mr Scott also holds 6,089 shares in certificated form. Other clients of Kestrel, in which Mr. Scott has no beneficial interest, hold 15,807,124 Ordinary Shares in the Company.

 

On a combined basis, Kestrel indirectly holds voting rights over 32,528,519 Ordinary Shares in the Company, which represents approximately 20.42 per cent of the total voting rights in the Company.

 

Kestrel's interest in the Shares in the Company is held through the following nominees:

 

Nominee

No. of Ordinary Shares

% of total

voting rights

Bank of New York Nominees Ltd

16,715,306

10.49%

Bank of New York Nominees Ltd

12,485,870

7.84%

Northern Trust Company AVFC

3,105,436

1.95%

iDealing Nominees Limited

215,818

0.14%

Certificated Shares held by Oliver Scott

6,089

0.00%

 

Enquiries:

 

 

Redcentric plc

Michelle Senecal De Fonesca, CEO

Tony Ratcliffe, CFO

 

Via Burson Buchanan

www.redcentricplc.com

Cavendish Capital Markets Limited (NOMAD and Sole Broker)

Marc Milmo / Callum Davidson (Corporate Finance)

Andrew Burdis / Sunila de Silva (ECM)

 

Tel: +44 (0) 20 7220 0500

 

 

For media enquiries:

 

Burson Buchanan - Financial Communications

Henry Harrison-Topham / Jamie Hooper / Toto Berger

 

 

Tel: +44 (0) 20 7466 5000 redcentric@buchanancomms.co.uk

 

ANNEX

 

Template for notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them.

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 

Oliver Scott

 

2

 

Reason for the notification

 

a)

 

Position/status

 

 

PCA - Kestrel Partners LLP are a PCA of Oliver Scott (non-executive director of Redcentric plc and Managing Partner of Kestrel).

b)

 

Initial notification /Amendment

Initial

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

Redcentric plc

b)

 

LEI

 

213800FGYMMNE9OKFD14

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

 

Description of the financial instrument, type of instrument

Identification code

0.1 pence Ordinary Shares

 

ISIN: GB00B7TW1V39

b)

 

Nature of the transaction

Transfer of Shares out of Kestrel controlled accounts. Mr. Scott is a partner of, and holds a beneficial interest in, Kestrel. Mr. Scott is also a shareholder in one of Kestrel's clients ("Kestrel Opportunities") and is, therefore, deemed to have a beneficial interest in Kestrel Opportunities' entire legal holding in Shares in Redcentric.

c)

 

Price(s) and volume(s)

 

 

Price(s)

Volume(s)

N/A

19,500

d)

 

Aggregated information

- Aggregated volume

- Price

 

As above.

e)

 

Date of the transaction

 

07 April 2026

f)

 

Place of the transaction

London Stock Exchange

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHAKFBPDBKDBQK
Date   Source Headline
1st Jun 20267:01 amRNSAppointment of Chief Financial Officer
1st Jun 20267:00 amRNSTrading Update
13th May 20261:25 pmRNSCapital Reduction Result of General Meeting
12th May 20267:00 amRNSExercise of Options
1st May 20267:00 amRNSCompletion of Sale of Redcentric Data Centres Ltd
24th Apr 20267:00 amRNSProposed Capital Reduction & Notice of GM
14th Apr 20267:00 amRNSExercise of Options
8th Apr 202612:55 pmRNSDirector/PDMR Shareholdings
19th Mar 20263:26 pmRNSExercise of Options
13th Mar 20267:00 amRNSExercise of Options
13th Mar 20267:00 amRNSExercise of Options
23rd Feb 20261:00 pmRNSHolding(s) in Company
20th Feb 20267:00 amRNSExercise of Options
9th Jan 202610:09 amRNSExercise of Options
31st Dec 202512:15 pmRNSDirector/PDMR Share Dealing
31st Dec 202512:15 pmRNSDirector/PDMR Share Dealing
31st Dec 20257:00 amRNSExercise of Options
31st Dec 20257:00 amRNSExercise of Options
29th Dec 20257:01 amRNSDirector/PDMR Share Dealing
29th Dec 20257:01 amRNSDirector/PDMR Share Dealing
29th Dec 20257:00 amRNSReplacement: Director/PDMR Share Dealing
29th Dec 20257:00 amRNSReplacement: Director/PDMR Share Dealing
24th Dec 20259:55 amRNSDirector/PDMR Share Dealing
24th Dec 20259:55 amRNSDirector/PDMR Share Dealing
22nd Dec 202511:46 amRNSGrant of Options
22nd Dec 202511:46 amRNSGrant of Options
12th Dec 20253:49 pmRNSDirector/PDMR Shareholdings
11th Dec 20257:00 amRNSExercise of Options
10th Dec 20257:00 amRNSHalf Year Results
4th Dec 20257:00 amRNS-RPresentation via Investor Meet Company
14th Nov 20257:00 amRNSExercise of Options
6th Nov 20258:00 amRNSSAYE Share Option Scheme
5th Nov 20257:00 amRNSH1 Trading Update and Notice of Results
27th Oct 20254:36 pmRNSHolding(s) in Company
24th Oct 20257:00 amRNSExercise of Options
23rd Oct 20257:00 amRNSDisposal of Redcentric Data Centres Limited
20th Oct 20254:48 pmRNSResult of AGM
17th Oct 202512:40 pmRNSExercise of Options
13th Oct 20259:40 amRNSExercise of Options
3rd Oct 20257:00 amRNSExercise of Options
25th Sep 20257:00 amRNSPublication of Annual Report and Notice of AGM
24th Sep 20257:00 amRNSFinal Results
2nd Sep 20257:00 amRNSNotice of Final Results
22nd Aug 20251:13 pmRNSResponse to recent press speculation
19th Aug 20257:00 amRNSAppointment of Chief Financial Officer
1st Aug 20257:00 amRNSExercise of Options
7th Jul 20257:00 amRNSExercise of Options
23rd Jun 20257:00 amRNSExercise of Options
17th Jun 20257:00 amRNSHolding(s) in Company
28th May 20253:59 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.